Chronic stable angina epidemiology and demographics: Difference between revisions
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
{{CMG}} | {{CMG}} | ||
'''Associate Editor- | '''Associate Editor-In-Chief:''' {{CZ}} | ||
{{EJ}} | {{EJ}} | ||
Revision as of 15:38, 3 September 2009
Cardiology Network |
Discuss Chronic stable angina epidemiology and demographics further in the WikiDoc Cardiology Network |
Adult Congenital |
---|
Biomarkers |
Cardiac Rehabilitation |
Congestive Heart Failure |
CT Angiography |
Echocardiography |
Electrophysiology |
Cardiology General |
Genetics |
Health Economics |
Hypertension |
Interventional Cardiology |
MRI |
Nuclear Cardiology |
Peripheral Arterial Disease |
Prevention |
Public Policy |
Pulmonary Embolism |
Stable Angina |
Valvular Heart Disease |
Vascular Medicine |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [3] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Click here for the Chronic stable angina main page
Overview
As the population ages, ischemic heart disease is projected to be a major public health concern worldwide. Currently, more than 6.5 million of American suffers from chronic stable angina pectoris. This is considered to be the initial manifestation of ischemic heart disease in approximately 50% of the patients.
All forms of coronary heart disease are much less common in the Third World countries, as the risk factors for coronary artery disease are much more common in Western and Westernized countries. Chronic stable angina could therefore be considered to be one of several diseases of affluence. Ischemic heart disease remains the single leading cause of death in United States. In Europe, CAD accounts for 49% of all deaths. It is estimated that about 30-35% patients never return to work after coronary revascularization and about 15-20% patients have significant limitation in their exercise and working capacity. This adds to the global disease burden from CAD
Increases in smoking, obesity and other modifiable risk factors has led to recent increases in chronic stable angina pectoris prevalence and related diseases in countries such as China.